The latest and updated research report on the Global Reproductive Genetics Market covers a comprehensive overview of the Reproductive Genetics market, future economic condition, competitive landscape mapping, supply and demand trends, and production and consumption analysis. The report also covers the influence of the COVID-19 pandemic on the Reproductive Genetics market. The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact.Increasing investment by major companies and rising demand for genetic testing, and improvement in reimbursement policies for medical tests are key growth driving factors

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/695

Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.

Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc.

Chromosomal abnormalities are responsible for 50% of miscarriages in first trimester. Reproductive genetics identifies embryos without these abnormalities so that they can be used for IVF, thus increasing the likelihood of healthy pregnancy and baby regardless of patient health. It also helps in achieving higher pregnancy rates per transfer, which reduces the need for IVF and results in low cost, time, and stress.

Additionally, the report also gives an insight into product portfolios, costs, sales, production capacities, and market players. Raw materials, demand analysis, product flow, and distribution channels have been studied and surveyed extensively in this research report. The key growth trends and opportunities are offered through a thorough investigation and examination of the market. A detailed course of development is offered in the report along with insights into businesses connected with it, which include firms, industries, organizations, vendors, and local manufacturers.

Some tests are quite expensive, which deters couples from going ahead with the tests, but as there is a decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of  couples/individuals are expected to opt for the procedure and this is expected to support market growth going ahead.

Prenatal screening covers a variety of tests doctors recommend for a pregnant patient. Some prenatal screening tests determines the chances a baby may or may not have chromosomal disorders, such as Down Syndrome. Though recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood work.

Reproductive Genetics is a widely accepted genetic testing technology in the prenatal testing arena. NGS is able to detect embryos with unbalanced chromosomal translocations that were not identified earlier. NGS offers better coverage of the chromosomes, higher resolution, and is faster and more affordable.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/695

Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:

Product Type Outlook (Revenue, USD Billion; 2018–2028)

• Laboratory Developed Tests (LDT)
• Kits
• Reagents and Consumables

Procedure Type Outlook (Revenue, USD Billion; 2018–2028)

• Pre-Natal Screening
• Pre-Implantation Genetic Testing
• Infertility Genetic Testing
• Carrier Screening

Technology Outlook (Revenue, USD Billion; 2018–2028)

• Next-Generation Sequencing (NGS)
• Microarray
• Polymerase chain reaction (PCR)
• In-Situ Hybridization (ISH)

Application Outlook (Revenue, USD Billion; 2018–2028)

• Single Gene Disorder
• Aneuploidy
• Structural Chromosomal Abnormality
• Others

Regional Outlook (Revenue, USD Billion; 2018–2028)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. U.K.
  3. France
  4. Spain
  5. BENELUX
  6. Rest of Europe
• Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East Africa
  1. Saudi Arabia
  2. UAE
  3. Israel
  4. Rest Of MEA

Key questions addressed in the report:

• What are the key factors driving the global Reproductive Genetics market?
• Who are the key manufacturers in this market space?
• Who are the distributors, traders and dealers of this market?
• What are the market opportunities and risks affecting the performance of the vendors in the global Reproductive Genetics market?
• What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?

Read More: https://www.emergenresearch.com/industry-report/reproductive-genetics-market

Related reports:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

In-Vitro Fertilization Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

 About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research  and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs